日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase Ib/II trial of talimogene laherparepvec alone and with pembrolizumab in advanced solid tumors with liver metastases and hepatocellular carcinoma

一项针对伴有肝转移的晚期实体瘤和肝细胞癌的talimogene laherparepvec单药治疗及联合pembrolizumab治疗的Ib/II期临床试验

Hecht, Joel Randolph; Oberoi, Arjun; Garralda Cabanas, Elena; Jae Chon, Hong; Digklia, Antonia; Rottey, Sylvie; Martin Jimenez, Miguel; Chaney, Marya; Hippenmeyer, Jane; Lawrence, Tatiana; Liu, Kate; Hamidi, Ali; Chesney, Jason

Regorafenib plus nivolumab in unresectable hepatocellular carcinoma: the phase 2 RENOBATE trial

瑞戈非尼联合纳武利尤单抗治疗不可切除的肝细胞癌:RENOBATE II期试验

Hyung-Don Kim # ,Seyoung Jung # ,Ho Yeong Lim ,Baek-Yeol Ryoo ,Min-Hee Ryu ,Samuel Chuah ,Hong Jae Chon ,Beodeul Kang ,Jung Yong Hong ,Han Chu Lee ,Deok-Bog Moon ,Ki-Hun Kim ,Tae Won Kim ,David Tai ,Valerie Chew ,Jeong Seok Lee ,Richard S Finn ,June-Young Koh ,Changhoon Yoo

Oral reovirus reshapes the gut microbiome and enhances antitumor immunity in colon cancer

口服呼肠孤病毒重塑肠道微生物群并增强结肠癌的抗肿瘤免疫力

Won Suk Lee #, Seung Joon Lee #, Hye Jin Lee #, Hannah Yang, Eun-Jin Go, Enkhtaivan Gansukh, Ki-Hoon Song, Xiao Xiang, Dong Guk Park, Tommy Alain, Hong Jae Chon, Chan Kim

Thyroid Dysfunction after Atezolizumab and Bevacizumab Is Associated with Favorable Outcomes in Hepatocellular Carcinoma

阿替利珠单抗和贝伐单抗治疗后出现的甲状腺功能障碍与肝细胞癌的良好预后相关

Young Shin Song, Hannah Yang, Beodeul Kang, Jaekyung Cheon, Ilhwan Kim, Hyeyeong Kim, Won Suk Lee, Yun Beom Sang, Sanghoon Jung, Ho Yeong Lim, Vincent E Gaillard, Chan Kim, Hong Jae Chon

High serum IL-6 correlates with reduced clinical benefit of atezolizumab and bevacizumab in unresectable hepatocellular carcinoma

血清 IL-6 水平升高与不可切除性肝细胞癌中阿替利珠单抗和贝伐单抗的临床益处降低相关

Hannah Yang, Beodeul Kang, Yeonjung Ha, Sung Hwan Lee, Ilhwan Kim, Hyeyeong Kim, Won Suk Lee, Gwangil Kim, Sanghoon Jung, Sun Young Rha, Vincent E Gaillard, Jaekyung Cheon, Chan Kim, Hong Jae Chon

Intratumoral immunotherapy using a TLR2/3 agonist, L-pampo, induces robust antitumor immune responses and enhances immune checkpoint blockade

使用 TLR2/3 激动剂 L-pampo 进行肿瘤内免疫治疗可诱导强大的抗肿瘤免疫反应并增强免疫检查点阻断

Won Suk Lee #, Dong Sung Kim #, Jeong Hun Kim #, Yoonki Heo, Hannah Yang, Eun-Jin Go, Jin Hyoung Kim, Seung Joon Lee, Byung Cheol Ahn, Jung Sun Yum, Hong Jae Chon, Chan Kim

High Serum Levels of IL-6 Predict Poor Responses in Patients Treated with Pembrolizumab plus Axitinib for Advanced Renal Cell Carcinoma

血清 IL-6 水平高预示晚期肾细胞癌患者接受派姆单抗联合阿昔替尼治疗反应不佳

Yun Beom Sang, Hannah Yang, Won Suk Lee, Seung Joon Lee, Seul-Gi Kim, Jaekyung Cheon, Beodeul Kang, Chang Woo Kim, Hong Jae Chon, Chan Kim

STING activation normalizes the intraperitoneal vascular-immune microenvironment and suppresses peritoneal carcinomatosis of colon cancer

STING 激活使腹膜内血管免疫微环境正常化并抑制结肠癌的腹膜癌变

Seung Joon Lee #, Hannah Yang #, Woo Ram Kim #, Yu Seong Lee, Won Suk Lee, So Jung Kong, Hye Jin Lee, Jeong Hun Kim, Jaekyung Cheon, Beodeul Kang, Hong Jae Chon, Chan Kim

Combination of Irreversible Electroporation and STING Agonist for Effective Cancer Immunotherapy

不可逆电穿孔与 STING 激动剂联合用于有效的癌症免疫治疗

Eun-Jin Go, Hannah Yang, Hong Jae Chon, DaSom Yang, WonHyoung Ryu, Dong-Hyun Kim, Dong Keun Han, Chan Kim, Wooram Park

Rho GTPase RhoJ is Associated with Gastric Cancer Progression and Metastasis

Rho GTPase RhoJ 与胃癌进展和转移相关

Chan Kim, Hannah Yang, Intae Park, Hong Jae Chon, Joo Hoon Kim, Woo Sun Kwon, Won Suk Lee, Tae Soo Kim, Sun Young Rha